• bitcoinBitcoin(BTC)$84,548.000.63%
  • ethereumEthereum(ETH)$2,686.330.37%
  • tetherTether(USDT)$1.00-0.01%
  • binancecoinBNB(BNB)$777.421.00%
  • rippleXRP(XRP)$1.520.62%
  • usd-coinUSDC(USDC)$1.00-0.01%
  • solanaSolana(SOL)$122.701.83%
  • tronTRON(TRX)$0.333655-0.41%
  • zcashZcash(ZEC)$1,604.531.57%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.062.90%
  • HyperliquidHyperliquid(HYPE)$91.630.08%
  • dogecoinDogecoin(DOGE)$0.0969510.99%
  • chainlinkChainlink(LINK)$14.020.19%
  • moneroMonero(XMR)$547.17-0.89%
  • whitebitWhiteBIT Coin(WBT)$84.310.62%
  • USDSUSDS(USDS)$1.00-0.01%
  • cardanoCardano(ADA)$0.2548281.59%
  • RainRain(RAIN)$0.012554-2.19%
  • leo-tokenLEO Token(LEO)$9.050.98%
  • stellarStellar(XLM)$0.2159770.26%
  • nearNEAR Protocol(NEAR)$5.4714.20%
  • bitcoin-cashBitcoin Cash(BCH)$333.840.02%
  • uniswapUniswap(UNI)$9.692.00%
  • litecoinLitecoin(LTC)$71.24-0.34%
  • CantonCanton(CC)$0.1379893.58%
  • suiSui(SUI)$1.2610.51%
  • Ethena USDeEthena USDe(USDE)$1.000.02%
  • avalanche-2Avalanche(AVAX)$10.962.75%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.643.75%
  • daiDai(DAI)$1.00-0.01%
  • USD1USD1(USD1)$1.00-0.02%
  • hedera-hashgraphHedera(HBAR)$0.0945822.07%
  • BittensorBittensor(TAO)$325.013.18%
  • shiba-inuShiba Inu(SHIB)$0.0000060.62%
  • crypto-com-chainCronos(CRO)$0.0673782.95%
  • BitwayBitway(BTW)$1.2117.61%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • quant-networkQuant(QNT)$198.3764.95%
  • EthenaEthena(ENA)$0.2815904.79%
  • paypal-usdPayPal USD(PYUSD)$1.000.00%
  • MemeCoreMemeCore(M)$1.19-1.88%
  • OndoOndo(ONDO)$0.553.12%
  • tether-goldTether Gold(XAUT)$4,278.21-0.04%
  • okbOKB(OKB)$121.450.87%
  • Ripple USDRipple USD(RLUSD)$1.00-0.01%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • aaveAave(AAVE)$154.350.17%
  • Pump.funPump.fun(PUMP)$0.00500715.44%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.11%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

CNN’s Christiane Amanpour diagnosed with ovarian cancer again

October 24, 2025
in Business
Reading Time: 4 mins read
A A
CNN’s Christiane Amanpour diagnosed with ovarian cancer again
ShareShareShareShareShare

CNN anchor Christiane Amanpour revealed she is once again battling ovarian cancer — four years after her first diagnosis — and urged women to pay attention to warning signs.

YOU MAY ALSO LIKE

Solidcore signs deal for Upper East Side location

Rob Bonta’s Paramount-WBD debacle has created political chaos

The veteran journalist disclosed that the disease had returned in what doctors described as a “fairly rare” form, but said her outlook remains positive.

“I have it again but it’s being very well managed and so this is one of the whole things that people have to understand about some cancers,” Amanpour said on Thursday’s episode of the “Changing the Ovarian Cancer Story” podcast.

CNN anchor Christiane Amanpour revealed she is once again battling ovarian cancer. World Ovarian Cancer Coalition

She told listeners her cancer was now classified as “stage 1/2,” meaning it was in its earliest phase but had “adhered a little bit to my pelvis.”

“Angela told me what it was and why I was potentially lucky because there were actually pain symptoms,” Amanpour said, referring to her gynecologic oncology consultant, Dr. Angela George.

“There’s often no symptoms so many women don’t know, so I feel that I was lucky.”

Amanpour’s relapsed ovarian cancer appeared earlier this year – her third bout in four years – and her oncologist treated her with a two-year immunotherapy treatment, which has helped get it under control, The Post has learned.

George confirmed that Amanpour’s ovarian cancer is currently in remission thanks to her regimen of immunotherapy.

Amanpour has managed her treatment around her demanding schedule for both CNN and her podcast, The Ex Files with Jamie Rubin,” with little to no disruption, according to a source with knowledge of the situation.

The veteran journalist disclosed that the disease had returned in what doctors described as a “fairly rare” form, but said her outlook remains positive. @amanpour/X

Amanpour considers herself fortunate that her particular type of ovarian cancer – which is quite rare – has responded well to immunotherapy treatment.

Amanpour, 67, encouraged other women to be proactive about their health and seek medical attention if something feels wrong.

“I wanted to say listen to your body because part of the reason I got such quick care was because I listened to my body and went straight to the doctors,” she said.

She added that she chose to speak publicly about her illness to serve others facing similar challenges.

Amanpour revealed her initial diagnosis back in 2021.

“I decided when I got back in front of the camera after four weeks — which included the surgery and a couple of weeks of recuperation before I started chemotherapy — I decided to say something because I actually wanted to do a service not just to my viewers, but also to those who might be in a similar situation,” Amanpour said.

Amanpour’s disclosure about her health four years ago drew messages of support from colleagues and viewers around the world.

Her latest announcement comes amid a tumultuous period for both CNN and its parent company, Warner Bros. Discovery.

Amanpour, one of CNN’s longest-serving correspondents, has continued working in recent weeks as the network faced fallout from her earlier remarks about Israeli hostages.

Amanpour caused a stir earlier this month when offering commentary on the Israel-Hamas ceasefire agreement. REUTERS

On Oct. 13, during coverage of the final release of captives held by Hamas, Amanpour said the hostages “were probably being treated better than the average Gazan, because they are the pawns and the chips that Hamas had.”

The comment sparked widespread backlash, prompting an on-air apology hours later.

“That was insensitive, and it was wrong,” Amanpour said at the time, recounting what freed hostages had endured underground.

Start your day with all you need to know

Morning Report delivers the latest news, videos, photos and more.

Thanks for signing up!

But her apology failed to satisfy some viewers — including Washington-based investor James Patterson, the widower of corporate activist Evelyn Y. Davis, who sent a letter to Warner Bros. Discovery CEO David Zaslav demanding her dismissal.

“As a stockholder in WBD, I urge you to fire Christiane Amanpour for her antisemitic statement that Israeli hostages were treated better than average Gazans,” Patterson wrote.

He told The Post he owns 300 shares of the company and has no intention of accepting Amanpour’s apology.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Solidcore signs deal for Upper East Side location
Business

Solidcore signs deal for Upper East Side location

September 27, 2026
Rob Bonta’s Paramount-WBD debacle has created political chaos
Business

Rob Bonta’s Paramount-WBD debacle has created political chaos

September 27, 2026
US jury says Apple owes record .7 billion in patent case against San Diego company
Business

US jury says Apple owes record $5.7 billion in patent case against San Diego company

September 27, 2026
Costco receives 4M in tariff refunds
Business

Costco receives $184M in tariff refunds

September 26, 2026
Next Post
What to expect as Israel prepares to greet Trump and receive hostages from Gaza

What to expect as Israel prepares to greet Trump and receive hostages from Gaza

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
New software helps California schools crack down on staff allegedly viewing explicit content

New software helps California schools crack down on staff allegedly viewing explicit content

September 26, 2026
Train operator appears to nod off before crash

Train operator appears to nod off before crash

September 24, 2026
Chris Van Hollen says he won’t reject DSA endorsement but ‘certainly not seeking’ it: Full interview

Chris Van Hollen says he won’t reject DSA endorsement but ‘certainly not seeking’ it: Full interview

September 25, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!